Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LACOSAMIDE USP, with a corresponding US DMF Number 26323.
Remarkably, this DMF maintains an Active status since its submission on October 15, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 13, 2013, and payment made on November 01, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II